| Accession Number | 0001632901-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 27, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP & Chief Medical Officer | Common Stock | โ | Feb 26, 2026 | Exercise/Conversion | 3,052 | $0.00 | $0.00 | 3,461 | Indirect | by Trust | View Details | |
EVP & Chief Medical Officer | Common Stock | โ | Feb 26, 2026 | Tax Withholding | 1,514 | $506.17 | $766,341.38 | 1,947 | Indirect | by Trust | View Details | |
EVP & Chief Medical Officer | Common Stock | โ | Feb 26, 2026 | Exercise/Conversion | 1,602 | $0.00 | $0.00 | 3,549 | Indirect | by Trust | View Details | |
EVP & Chief Medical Officer | Common Stock | โ | Feb 26, 2026 | Tax Withholding | 795 | $506.17 | $402,405.15 | 2,754 | Indirect | by Trust | View Details | |
EVP & Chief Medical Officer | Performance Stock Units - 2-28-2023 | Derivative | Feb 26, 2026 | Grant/Award | 2,793 | $0.00 | $0.00 | 8,378 | Direct | โ | View Details | |
EVP & Chief Medical Officer | Restricted Stock Units - 2-26-2024 | Derivative | Feb 26, 2026 | Exercise/Conversion | 3,052 | $0.00 | $0.00 | 3,053 | Direct | โ | View Details | |
EVP & Chief Medical Officer | Restricted Stock Units - 2-26-2025 | Derivative | Feb 26, 2026 | Exercise/Conversion | 1,602 | $0.00 | $0.00 | 0 | Direct | โ | View Details |